MML Investors Services’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,240
| Closed | -$391K | – | 2584 |
|
|
2024
Q2 | $391K | Sell |
7,240
-1,821
| -20% | -$98.3K | ﹤0.01% | 1932 |
|
|
2024
Q1 | $618K | Sell |
9,061
-2,950
| -25% | -$201K | ﹤0.01% | 1677 |
|
|
2023
Q4 | $752K | Sell |
12,011
-12,645
| -51% | -$792K | ﹤0.01% | 1523 |
|
|
2023
Q3 | $1.12M | Buy |
24,656
+3,930
| +19% | +$178K | 0.01% | 1165 |
|
|
2023
Q2 | $1.16M | Buy |
+20,726
| New | +$1.16M | 0.01% | 1162 |
|
|
2023
Q1 | – | Sell |
-15,090
| Closed | -$613K | – | 2118 |
|
|
2022
Q4 | $613K | Buy |
15,090
+1,729
| +13% | +$70.2K | ﹤0.01% | 1398 |
|
|
2022
Q3 | $873K | Buy |
13,361
+1,484
| +12% | +$97K | 0.01% | 1126 |
|
|
2022
Q2 | $722K | Buy |
11,877
+5,346
| +82% | +$325K | 0.01% | 1207 |
|
|
2022
Q1 | $410K | Buy |
6,531
+2,117
| +48% | +$133K | ﹤0.01% | 1561 |
|
|
2021
Q4 | $334K | Sell |
4,414
-1,046
| -19% | -$79.1K | ﹤0.01% | 1642 |
|
|
2021
Q3 | $611K | Buy |
5,460
+269
| +5% | +$30.1K | ﹤0.01% | 1250 |
|
|
2021
Q2 | $840K | Buy |
5,191
+1,175
| +29% | +$190K | 0.01% | 1073 |
|
|
2021
Q1 | $489K | Sell |
4,016
-172
| -4% | -$20.9K | ﹤0.01% | 1280 |
|
|
2020
Q4 | $641K | Buy |
+4,188
| New | +$641K | 0.01% | 1036 |
|